stars 1 stars 2 stars 3

Libera Bio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface, transmembrane or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins. << Fraud Alert for Potential Candidates >> At Libera Bio, your personal information and online safety are our top priorities. • Candidates should apply exclusively through our official webpage at https://www.liberabio.com/contact/ or rrhh@liberabio.com. • If we collaborate with recruiters, they will always represent well-established and reputable firms. • We will NEVER ask for payments, financial account details, or sensitive data like social security numbers during the recruitment process. Stay safe

Website http://www.liberabio.com
Employees 9 (4 on RocketReach)
Founded 2018
Technologies
Industry Biotechnology Research
Competitors Moderna Therapeutics, CureVac, Zymergen, Inc., Regeneron, Roche, Novartis, Sanofi, Amgen, Pfizer, AstraZeneca +37 more (view full list)

LiberaBio Questions

Desirée Teijeiro Osorio is the CEO of LiberaBio.

4 people are employed at LiberaBio.

LiberaBio is based in Santiago de Compostela, Galicia.

Top LiberaBio Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users